
Page 144 of 276
Annual Financial Report as of 31.12.2021
Amounts in thousand Euro, unless stated otherwise
Impairment assessment of Goodwill
(Consolidated Financial Statements)
In the consolidated statement of financial
position as at 31 December 2021, the Group
has goodwill of € 9.8 million as stated in note
3.15 "Intangible Assets" of the financial
statements.
The Group measures goodwill at cost less
accumulated impairment losses.
Goodwill is allocated on cash-generating units
and an impairment test is carried out annually or
more frequently if there is evidence of a
possible impairment in the book value of the
goodwill in relation to its recoverable value in
accordance with IAS 36. Impairment is
recognized directly as an expense in
consolidated profit or loss and other
comprehensive income and is not subsequently
reversed.
Management determines recoverable value of
the cash generating units as the largest amount
between the value in use and its fair value,
minus any related costs of disposal. The
calculation of the value in use of each cash-
generating unit is performed by an independent
valuer and requires management's estimation of
the assumptions about the future results of the
above cash-generating units, such as the
growth rate in perpetuity, forecasts of expected
sales quantities and prices, gross margin and
discount rates. These assumptions vary due to
the different market conditions in the countries
in which the Group operates.
We focused on this area due to the significant
value of this item in the consolidated financial
statements as well as the estimates and
assumptions used by management in the
context of performing the impairment
assessment of goodwill.
Detailed information on the impairment
assessment of goodwill is provided in notes
2.3.1.3 "Estimation of impairment assessment
of goodwill”, 2.6.1 “Goodwill”, 2.6.2 “Impairment
assessment of goodwill” and 3.15 "Intangible
assets" of the consolidated financial statements
of the Group.
Based on the impairment test performed by
management, there was no need to recognize
impairment loss on goodwill for the year ended
31 December 2021.
We evaluated the overall impairment test
performed by the management, including the
process of reviewing and approving value in
use models.
We performed audit procedures to confirm
that the impairment test for goodwill is
generally based on accepted policies and on
reasonable assumptions. In cooperation with
our colleagues with valuation expertise, we
performed the following audit procedures:
We examined the key assumptions of the
Group, such as the growth rate of the cash
generating units in perpetuity, projected sales
volumes and prices, and gross profit margins
used in the projected cash flow, comparing
them with the trends of local markets and the
assumptions used in previous years.
We evaluated the reliability of the forecasts
used in the projected cash flows of the
management, by comparing the actual
performance against previous forecasts.
We found that the discount rate was
determined within an acceptable range,
assessing the cost of capital and borrowing
costs per cash-generating unit and comparing
the discount rates with industry and market
data.
We examined the mathematical accuracy of
the cash flow models and we agreed these
with the relative investment plans. We
assessed the impact on the value in use of the
cash-generating units of a possible change in
the key assumptions, such as growth rates,
discount rates, sales volume and prices, and
gross profit margins, and we found that the
margin between book value and recoverable
value was adequate.
Based on the procedures performed, no
exceptions were identified regarding the
impairment test and we found that
management's assumptions and estimates
were within a reasonable range. In addition,
we confirmed the appropriateness of the
relevant disclosures in the consolidated
financial statements.
Impairment assessment of investment in
Subsidiaries (Separate Financial Statements)
As at 31 December 2021, the Company held
investments in subsidiaries amounting to €73.9
million, which are measured at cost, and
We evaluated the management's assessment
and resulting conclusions over the existence